Treatment of rheumatic carditis with intravenous gammaglobulin: Is there a beneficial effect?

Karim A. Diab; Majd Ariss Timani; Fadi F. Bitar

doi:10.1017/s1047951101000841

Treatment of rheumatic carditis with intravenous gammaglobulin: Is there a beneficial effect?

Karim A. Diab, Majd Ariss Timani, Fadi F. Bitar^*

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Rheumatic carditis is a major manifestation of acute rheumatic fever. Conventional therapy includes the use of salicylates and steroids. To date, however, such therapy has not been proven to have a clear benefit in reducing valvar heart disease. We report the use of high-dose intravenous immunoglobulin in two chidlren with acute rheumatic carditis in whom we have been able to document the beneficial effect.

Original language	English (US)
Pages (from-to)	565-567
Number of pages	3
Journal	Cardiology in the young
Volume	11
Issue number	5
DOIs	https://doi.org/10.1017/s1047951101000841
State	Published - 2001

Keywords

Acute rheumatic fever
Carditis
Intravenous immunoglobulin

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Pediatrics, Perinatology, and Child Health

Access to Document

10.1017/s1047951101000841

Cite this

@article{d8fa4ffb64fa4945b20168252051122f,

title = "Treatment of rheumatic carditis with intravenous gammaglobulin: Is there a beneficial effect?",

abstract = "Rheumatic carditis is a major manifestation of acute rheumatic fever. Conventional therapy includes the use of salicylates and steroids. To date, however, such therapy has not been proven to have a clear benefit in reducing valvar heart disease. We report the use of high-dose intravenous immunoglobulin in two chidlren with acute rheumatic carditis in whom we have been able to document the beneficial effect.",

keywords = "Acute rheumatic fever, Carditis, Intravenous immunoglobulin",

author = "Diab, {Karim A.} and Timani, {Majd Ariss} and Bitar, {Fadi F.}",

year = "2001",

doi = "10.1017/s1047951101000841",

language = "English (US)",

volume = "11",

pages = "565--567",

journal = "Cardiology in the young",

issn = "1047-9511",

publisher = "Cambridge University Press",

number = "5",

}

TY - JOUR

T1 - Treatment of rheumatic carditis with intravenous gammaglobulin

T2 - Is there a beneficial effect?

AU - Diab, Karim A.

AU - Timani, Majd Ariss

AU - Bitar, Fadi F.

PY - 2001

Y1 - 2001

N2 - Rheumatic carditis is a major manifestation of acute rheumatic fever. Conventional therapy includes the use of salicylates and steroids. To date, however, such therapy has not been proven to have a clear benefit in reducing valvar heart disease. We report the use of high-dose intravenous immunoglobulin in two chidlren with acute rheumatic carditis in whom we have been able to document the beneficial effect.

AB - Rheumatic carditis is a major manifestation of acute rheumatic fever. Conventional therapy includes the use of salicylates and steroids. To date, however, such therapy has not been proven to have a clear benefit in reducing valvar heart disease. We report the use of high-dose intravenous immunoglobulin in two chidlren with acute rheumatic carditis in whom we have been able to document the beneficial effect.

KW - Acute rheumatic fever

KW - Carditis

KW - Intravenous immunoglobulin

UR - http://www.scopus.com/inward/record.url?scp=0035460766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035460766&partnerID=8YFLogxK

U2 - 10.1017/s1047951101000841

DO - 10.1017/s1047951101000841

M3 - Article

C2 - 11727916

AN - SCOPUS:0035460766

SN - 1047-9511

VL - 11

SP - 565

EP - 567

JO - Cardiology in the young

JF - Cardiology in the young

IS - 5

ER -

Treatment of rheumatic carditis with intravenous gammaglobulin: Is there a beneficial effect?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this